APOPTOSIS INDUCED BY SHIGELLA IpaB
申请公布号:WO1997026790(A1)
申请号:US1997000399
申请日期:1997.01.10
申请公布日期:1997.07.31
摘要:<p>Shigella IpaB protein or functional derivative binds to interleukin-1β-converting enzyme (ICE) or an ICE homologue and activates a program of apoptosis. DNA encoding the Shigella IpaB protein, the IpaB protein or a functional derivative thereof is provided to a eukaryotic, preferably human, cell to induce apoptosis of that cell. This approach useful in treating diseases or disorders treatable by the eradication of unwanted cells, including cancer, autoimmunity, inflammation and chronic viral infections. Protein or peptide molecules (and the DNA coding therefor) which act as competitive antagonists for ICE binding without activating the apoptosis program are useful in treating or preventing diseases which involve an apoptotic mechanism in their pathogenesis, for example AIDS, degenerative diseases such as Alzheimer's disease, myelodysplastic disorders, ischemic injuries or toxin-induced liver diseases. Various methods of gene therapy relying upon controlled expression of IpaB in a target cell are disclosed. Also provided are methods for: inhibiting the interaction of an apoptosis-inducing protein or peptide with ICE, detecting a compound capable of inhibiting the binding of IpaB to ICE or to an ICE homologue, screening a candidate protein or peptide for its ability to interact with IpaB in a cell, isolating from a complex mixture a compound capable of binding to IpaB protein.</p>
Improved methods for the determination and adjustment of prolactin daily rhythms
METHOD AND APPARATUS FOR TILTED ALIGNMENT OF LIQUID CRYSTALS WITH IMPROVED PHOTOSTABILITY
Containment of an aerosolable liquid jet
Rotator cuff development system
Method for obtaining sesquiterpene lactone, in particular parthenolide
Apparatus for controlling fuel vapor flow
Back up power source for a thermostat
Method and apparatus for measuring quantities relating to a person's cardiac activity
Linear motion, muscle-actuated cardiac assist device
1,2-disubstituted ethyl amides as inhibitors of acat